For example, stimulation of subthalamic nucleus (STN) or internal globus pallidus (GPi) in Parkinson's disease can have immediate effects on bradykinesia, whereas stimulation of GPi in either genetic or acquired dystonias usually has effects only weeks or months later (Herrington et al., 2016). This evidence concerns the gene GPI and Parkinson disease.